Business · 09/10/2008Updated: 10/17/2026 · 1 min read
FDA Announces Approval of Guidance for Industry: Cooperative Manufacturing Arrangements for Licensed Biologics
Summary
The Food and Drug Administration (FDA) has received approval from the Office of Management and Budget (OMB) for a guidance document on cooperative manufacturing arrangements for licensed biologics, as required by the Paperwork Reduction Act of 1995.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →